Bayer Aktiengesellschaft

XTRA:BAYN Stock Report

Market Cap: €18.6b

Bayer Future Growth

Future criteria checks 3/6

Bayer is forecast to grow earnings and revenue by 55.8% and 1% per annum respectively. EPS is expected to grow by 55.8% per annum. Return on equity is forecast to be 13.3% in 3 years.

Key information

55.8%

Earnings growth rate

55.8%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate1.0%
Future return on equity13.3%
Analyst coverage

Good

Last updated15 Dec 2024

Recent future growth updates

Bayer Aktiengesellschaft Just Missed Earnings; Here's What Analysts Are Forecasting Now

Aug 09
Bayer Aktiengesellschaft Just Missed Earnings; Here's What Analysts Are Forecasting Now

Recent updates

Benign Growth For Bayer Aktiengesellschaft (ETR:BAYN) Underpins Stock's 25% Plummet

Nov 21
Benign Growth For Bayer Aktiengesellschaft (ETR:BAYN) Underpins Stock's 25% Plummet

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Sep 13
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Bayer Aktiengesellschaft Just Missed Earnings; Here's What Analysts Are Forecasting Now

Aug 09
Bayer Aktiengesellschaft Just Missed Earnings; Here's What Analysts Are Forecasting Now

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Jun 11
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

May 07
The Market Doesn't Like What It Sees From Bayer Aktiengesellschaft's (ETR:BAYN) Revenues Yet

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt In A Risky Way

Jan 18
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt In A Risky Way

Are Investors Undervaluing Bayer Aktiengesellschaft (ETR:BAYN) By 42%?

Dec 27
Are Investors Undervaluing Bayer Aktiengesellschaft (ETR:BAYN) By 42%?

Earnings and Revenue Growth Forecasts

XTRA:BAYN - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202647,4092,8574,2297,30916
12/31/202546,5562,3324,0917,07717
12/31/202446,380-282,7595,56617
9/30/202446,739-8805,3037,978N/A
6/30/202447,113-1,2665,6908,443N/A
3/31/202447,013-3,1193,7866,517N/A
12/31/202347,637-2,9412,3665,117N/A
9/30/202347,775-3,667-5082,571N/A
6/30/202348,7141,448-4732,649N/A
3/31/202350,4893,0371,2034,269N/A
12/31/202250,7394,1504,1447,093N/A
9/30/202249,8574,7004,3137,078N/A
6/30/202248,3574,2394,5477,235N/A
3/31/202246,3922,2024,4977,128N/A
12/31/202144,0811,0002,4785,089N/A
9/30/202142,9582224302,794N/A
6/30/202141,683-7,565-3141,950N/A
3/31/202140,883-14,849112,367N/A
12/31/202041,400-15,5692,4854,903N/A
9/30/202042,155-15,9954,8057,398N/A
6/30/202043,479-7,3034,9407,713N/A
3/31/202044,1382,6314,2536,899N/A
12/31/201943,5452,3915,5578,207N/A
9/30/201943,150-1,5305,2217,929N/A
6/30/201942,5812875,0607,698N/A
3/31/201939,8565575,6998,338N/A
12/31/201836,7421,3745,3247,917N/A
9/30/201834,9836,0274,8337,218N/A
6/30/201833,7473,237N/A7,878N/A
3/31/201834,4733,486N/A7,951N/A
12/31/201735,0153,249N/A8,134N/A
9/30/201735,2423,087N/A8,597N/A
6/30/201735,4753,924N/A8,939N/A
3/31/201732,7693,991N/A8,608N/A
12/31/201634,9433,743N/A9,089N/A
9/30/201637,4053,837N/A8,234N/A
6/30/201640,1513,971N/A7,511N/A
3/31/201646,1464,210N/A7,488N/A
12/31/201546,0854,025N/A6,890N/A
9/30/201545,5923,616N/A7,243N/A
6/30/201544,5553,429N/A6,729N/A
3/31/201542,7803,206N/A6,371N/A
12/31/201441,3393,326N/A5,810N/A
9/30/201440,4353,569N/A5,160N/A
6/30/201440,1113,501N/A5,072N/A
3/31/201440,2433,425N/A5,007N/A
12/31/201340,1573,189N/A5,171N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BAYN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: BAYN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BAYN is expected to become profitable in the next 3 years.

Revenue vs Market: BAYN's revenue (1% per year) is forecast to grow slower than the German market (5.7% per year).

High Growth Revenue: BAYN's revenue (1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BAYN's Return on Equity is forecast to be low in 3 years time (13.3%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:52
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bayer Aktiengesellschaft is covered by 57 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Knut WollerBaader Helvea Equity Research
null nullBanco de Sabadell. S.A.